These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3580432)

  • 1. The influence of the muscarinic agonist RS 86 on the cortisol system.
    Krieg JC; Bossert S; Pirke KM; von Zerssen D; Berger M
    Biol Psychiatry; 1987 May; 22(5):573-82. PubMed ID: 3580432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REM sleep and cortisol response to the cholinergic challenge with RS 86 in normals and depressives.
    Krieg JC; Berger M
    Acta Psychiatr Scand; 1987 Nov; 76(5):600-2. PubMed ID: 3434333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic drugs as diagnostic and therapeutic tools in affective disorders.
    Berger M; Riemann D; Krieg C
    Acta Psychiatr Scand Suppl; 1991; 366():52-60. PubMed ID: 1897376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suckling and salsolinol attenuate responsiveness of the hypothalamic-pituitary-adrenal axis to stress: focus on catecholamines, corticotrophin-releasing hormone, adrenocorticotrophic hormone, cortisol and prolactin secretion in lactating sheep.
    Hasiec M; Tomaszewska-Zaremba D; Misztal T
    J Neuroendocrinol; 2014 Dec; 26(12):844-52. PubMed ID: 25205344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.
    Cohrs S; Röher C; Jordan W; Meier A; Huether G; Wuttke W; Rüther E; Rodenbeck A
    Psychopharmacology (Berl); 2006 Mar; 185(1):11-8. PubMed ID: 16432682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
    Buckley TM; Mullen BC; Schatzberg AF
    Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cholecystokinin octapeptide on the hypothalamic-pituitary-adrenal axis function and on vasopressin, prolactin and growth hormone release in humans.
    Calogero AE; Nicolosi AM; Moncada ML; Coniglione F; Vicari E; Polosa P; D'Agata R
    Neuroendocrinology; 1993 Jul; 58(1):71-6. PubMed ID: 8264858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
    van Duinen MA; Schruers KR; Maes M; Griez EJ
    J Psychopharmacol; 2005 May; 19(3):243-7. PubMed ID: 15888509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the hypothalamic-pituitary-adrenal axis with the opioid antagonist nalmefene.
    Geer EB; Landman RE; Wardlaw SL; Conwell IM; Freda PU
    Pituitary; 2005; 8(2):115-22. PubMed ID: 16379031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.
    Kano T; Sugihara H; Sudo M; Nagao M; Harada T; Ishizaki A; Nakajima Y; Tanimura K; Okajima F; Tamura H; Ishii S; Shibasaki T; Oikawa S
    Peptides; 2010 Apr; 31(4):657-61. PubMed ID: 20045717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children.
    Boner AL
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S32-9. PubMed ID: 11449204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and gender.
    Peskind ER; Raskind MA; Wingerson D; Pascualy M; Thal LJ; Dobie DJ; Wilkinson CW
    Biol Psychiatry; 1996 Jul; 40(1):61-8. PubMed ID: 8780856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Lange M; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3149-54. PubMed ID: 12843158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI; Grice JE; Crosbie GV; Walters MM; Jackson AJ; Jackson RV
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of androgen anabolic steroids and physical activity on the hypothalamic-pituitary-gonadal axis.
    Hengevoss J; Piechotta M; Müller D; Hanft F; Parr MK; Schänzer W; Diel P
    J Steroid Biochem Mol Biol; 2015 Jun; 150():86-96. PubMed ID: 25797375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
    Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salsolinol: a potential modulator of the activity of the hypothalamic-pituitary-adrenal axis in nursing and postweaning sheep.
    Hasiec M; Herman AP; Misztal T
    Domest Anim Endocrinol; 2015 Oct; 53():26-34. PubMed ID: 26057577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.